New computational model proposed for Alzheimer's disease

Network_TEAM March 27, 2022

0 Comments

ROCHESTER, Minn. — Mayo Clinic researchers have proposed a new model for mapping the symptoms of Alzheimer’s disease to brain anatomy. This model was developed by applying machine learning to patient brain imaging data. It uses the entire function of the brain rather than specific brain regions or networks to explain the relationship between brain anatomy and mental processing. The findings are reported in Nature Communications. “This new model can advance our understanding of how…

Categories: national-health-sources

Network_TEAM

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

Network_News December 8, 2022

The Critical State of Alzheimer’s and Dementia in Latinos

Alzheimer’s disease is a condition that impairs brain function and, over time, can cause memory, cognitive, and behavioral issues and eventually lead to death. The condition greatly impacts the health of the aging — especially Latinos. 14% of the American Latino population older than 65 are living with Alzheimer’s, compared with 10% of the White …
The post The Critical State of Alzheimer’s and Dementia in Latinos appeared first on Salud America.

Network_News April 11, 2024

FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision

The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.

Network_News June 15, 2021

0 Comments

How Texas is Tackling Alzheimer’s Disease Care

Alzheimer’s disease is an illness that affects the lives of many, and it impacts some Americans more than others. In fact, studies show that U.S. Latinos are 1.5 times more likely to develop Alzheimer’s than their White peers. That number is only going to get worse over time if dedicated action isn’t taken. The number of Latinos …
The post How Texas is Tackling Alzheimer’s Disease Care appeared first on Salud America.

Network_News January 14, 2021

0 Comments

The 1st Alzheimer’s Disease Research Center in Texas Will Tackle Dementia in Latinos

Today, the National Institute on Aging (NIA) of the National Institutes of Health (NIH) designated UT Health San Antonio and UT Texas Rio Grande Valley as an Alzheimer’s Disease Research Center to boost research and reduce the Alzheimer’s burden among Latinos, who suffer disparities in dementia. The new center is the first in Texas. It …
The post The 1st Alzheimer’s Disease Research Center in Texas Will Tackle Dementia in Latinos appeared first on Salud America.

Network_News September 9, 2021

0 Comments

Responses

You must be logged in to post a comment.

Related Articles

Responses